Results 241 to 250 of about 6,941,131 (310)

Detection of an outbreak of Mediterranean spotted fever in Primary Care

open access: yesAtención Primaria
Marina Satorres Pérez   +2 more
doaj   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz   +9 more
wiley   +1 more source

How to make Asthma Right Care ‘easy’ in primary care: learnings from the 2023 Asthma Right Care Summit

open access: yesnpj Primary Care Respiratory Medicine
Siân Williams   +7 more
doaj   +1 more source

Deprescribing in primary care

open access: yesSingapore Medical Journal
Chua, Adrian Leong Aik   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy